| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Injuries | 16 | 2015 | 734 | 3.070 |
Why?
|
| Brain Injuries, Traumatic | 6 | 2022 | 367 | 1.810 |
Why?
|
| Decompressive Craniectomy | 4 | 2021 | 13 | 1.740 |
Why?
|
| Recovery of Function | 5 | 2017 | 437 | 1.480 |
Why?
|
| Ganglia, Spinal | 6 | 2016 | 73 | 1.470 |
Why?
|
| Brain Neoplasms | 8 | 2023 | 1217 | 1.450 |
Why?
|
| Glioblastoma | 5 | 2020 | 333 | 1.300 |
Why?
|
| Stress, Psychological | 4 | 2022 | 557 | 1.240 |
Why?
|
| Neurodegenerative Diseases | 3 | 2023 | 253 | 1.170 |
Why?
|
| Blood-Brain Barrier | 6 | 2022 | 141 | 1.150 |
Why?
|
| Mental Disorders | 4 | 2020 | 828 | 1.130 |
Why?
|
| Neuronal Plasticity | 3 | 2018 | 274 | 1.080 |
Why?
|
| Spinal Cord Injuries | 4 | 2019 | 305 | 1.070 |
Why?
|
| Hippocampus | 7 | 2022 | 812 | 1.000 |
Why?
|
| Sciatic Neuropathy | 2 | 2016 | 6 | 1.000 |
Why?
|
| Brain | 9 | 2022 | 2945 | 0.960 |
Why?
|
| Wakefulness | 2 | 2023 | 98 | 0.930 |
Why?
|
| Spinal Cord | 4 | 2021 | 293 | 0.900 |
Why?
|
| Nerve Regeneration | 5 | 2014 | 86 | 0.890 |
Why?
|
| Neurons | 7 | 2016 | 1927 | 0.890 |
Why?
|
| Ketorolac | 1 | 2023 | 17 | 0.850 |
Why?
|
| Ultrasonics | 1 | 2023 | 36 | 0.850 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2022 | 9 | 0.840 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2022 | 43 | 0.820 |
Why?
|
| Disease Models, Animal | 16 | 2022 | 4267 | 0.820 |
Why?
|
| Astrocytes | 2 | 2023 | 250 | 0.790 |
Why?
|
| Neurosurgery | 2 | 2020 | 75 | 0.770 |
Why?
|
| Neuronavigation | 1 | 2021 | 7 | 0.750 |
Why?
|
| Cranial Sinuses | 1 | 2021 | 12 | 0.750 |
Why?
|
| Hydrocephalus | 1 | 2023 | 238 | 0.710 |
Why?
|
| Occupational Health | 1 | 2020 | 44 | 0.690 |
Why?
|
| Humans | 77 | 2023 | 123122 | 0.690 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 257 | 0.690 |
Why?
|
| Tissue Engineering | 4 | 2009 | 176 | 0.680 |
Why?
|
| Neurosurgical Procedures | 4 | 2020 | 297 | 0.670 |
Why?
|
| DNA Repair Enzymes | 1 | 2019 | 40 | 0.650 |
Why?
|
| DNA Modification Methylases | 1 | 2019 | 43 | 0.650 |
Why?
|
| Ultrasonography, Interventional | 1 | 2021 | 194 | 0.650 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 766 | 0.640 |
Why?
|
| Occupational Exposure | 1 | 2020 | 129 | 0.640 |
Why?
|
| Cervical Cord | 1 | 2019 | 9 | 0.640 |
Why?
|
| Neck Injuries | 1 | 2019 | 22 | 0.630 |
Why?
|
| Hemangioblastoma | 1 | 2018 | 12 | 0.630 |
Why?
|
| Sepsis | 1 | 2023 | 478 | 0.620 |
Why?
|
| Animals | 35 | 2023 | 33708 | 0.610 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 2017 | 16 | 0.590 |
Why?
|
| Ectopic Gene Expression | 1 | 2017 | 3 | 0.570 |
Why?
|
| Intervertebral Disc Degeneration | 1 | 2017 | 13 | 0.570 |
Why?
|
| Intervertebral Disc | 1 | 2017 | 12 | 0.570 |
Why?
|
| Rats | 12 | 2022 | 3631 | 0.560 |
Why?
|
| Solute Carrier Family 12, Member 2 | 1 | 2016 | 7 | 0.550 |
Why?
|
| Schwann Cells | 2 | 2014 | 59 | 0.550 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 2016 | 128 | 0.540 |
Why?
|
| Epilepsy, Post-Traumatic | 1 | 2016 | 11 | 0.540 |
Why?
|
| Emotions | 2 | 2016 | 363 | 0.540 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2017 | 353 | 0.530 |
Why?
|
| Myelin Proteins | 2 | 2014 | 76 | 0.530 |
Why?
|
| Male | 41 | 2021 | 60036 | 0.520 |
Why?
|
| Norepinephrine | 1 | 2016 | 175 | 0.510 |
Why?
|
| Vascular Neoplasms | 1 | 2016 | 32 | 0.510 |
Why?
|
| Neural Stem Cells | 2 | 2014 | 126 | 0.510 |
Why?
|
| Cerebellar Neoplasms | 1 | 2018 | 282 | 0.500 |
Why?
|
| Failed Back Surgery Syndrome | 1 | 2014 | 2 | 0.490 |
Why?
|
| Central Nervous System Diseases | 1 | 2016 | 105 | 0.490 |
Why?
|
| Cerebellum | 1 | 2018 | 414 | 0.480 |
Why?
|
| Middle Aged | 24 | 2021 | 25971 | 0.480 |
Why?
|
| Lumbar Vertebrae | 3 | 2023 | 107 | 0.480 |
Why?
|
| Action Potentials | 2 | 2016 | 499 | 0.480 |
Why?
|
| Young Adult | 13 | 2021 | 8864 | 0.480 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 360 | 0.480 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 376 | 0.470 |
Why?
|
| Neuralgia | 1 | 2014 | 42 | 0.470 |
Why?
|
| Peripheral Nervous System Neoplasms | 2 | 2004 | 12 | 0.470 |
Why?
|
| Meningioma | 1 | 2016 | 113 | 0.470 |
Why?
|
| Brain Injury, Chronic | 1 | 2014 | 21 | 0.470 |
Why?
|
| Neuroglia | 1 | 2016 | 193 | 0.460 |
Why?
|
| S100 Proteins | 1 | 2014 | 44 | 0.460 |
Why?
|
| Up-Regulation | 2 | 2016 | 864 | 0.460 |
Why?
|
| Receptors, Cell Surface | 2 | 2014 | 469 | 0.460 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2016 | 137 | 0.460 |
Why?
|
| Neurilemmoma | 2 | 2004 | 44 | 0.450 |
Why?
|
| Meningeal Neoplasms | 1 | 2016 | 177 | 0.450 |
Why?
|
| Adult | 23 | 2023 | 29030 | 0.450 |
Why?
|
| Craniotomy | 3 | 2023 | 106 | 0.450 |
Why?
|
| Neurologic Examination | 2 | 2014 | 192 | 0.450 |
Why?
|
| Athletic Injuries | 1 | 2014 | 57 | 0.440 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2014 | 142 | 0.430 |
Why?
|
| Mice, Inbred C57BL | 10 | 2022 | 4342 | 0.420 |
Why?
|
| Warfare | 1 | 2012 | 35 | 0.410 |
Why?
|
| Pandemics | 1 | 2020 | 1104 | 0.410 |
Why?
|
| Blast Injuries | 1 | 2012 | 58 | 0.410 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2018 | 1211 | 0.410 |
Why?
|
| Aged | 16 | 2020 | 19072 | 0.400 |
Why?
|
| Cell Transplantation | 1 | 2012 | 45 | 0.390 |
Why?
|
| Cervical Vertebrae | 3 | 2017 | 107 | 0.390 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2012 | 33 | 0.390 |
Why?
|
| Memory Disorders | 1 | 2014 | 235 | 0.390 |
Why?
|
| Sleep Wake Disorders | 1 | 2014 | 177 | 0.390 |
Why?
|
| Imipramine | 1 | 2011 | 18 | 0.380 |
Why?
|
| Aging | 2 | 2017 | 1173 | 0.360 |
Why?
|
| Cell Proliferation | 4 | 2021 | 2306 | 0.350 |
Why?
|
| Cognition Disorders | 2 | 2012 | 554 | 0.350 |
Why?
|
| GPI-Linked Proteins | 3 | 2023 | 93 | 0.340 |
Why?
|
| Female | 30 | 2021 | 65443 | 0.340 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 647 | 0.340 |
Why?
|
| Mice | 15 | 2023 | 17483 | 0.330 |
Why?
|
| Motor Activity | 1 | 2013 | 520 | 0.330 |
Why?
|
| Neoplastic Stem Cells | 3 | 2021 | 294 | 0.330 |
Why?
|
| Axons | 4 | 2021 | 380 | 0.330 |
Why?
|
| Nerve Sheath Neoplasms | 3 | 2009 | 21 | 0.330 |
Why?
|
| Peripheral Nerves | 1 | 2009 | 84 | 0.320 |
Why?
|
| Neurogenesis | 1 | 2011 | 196 | 0.320 |
Why?
|
| Adolescent | 12 | 2023 | 19091 | 0.320 |
Why?
|
| Critical Care | 2 | 2014 | 645 | 0.320 |
Why?
|
| Mass Screening | 1 | 2014 | 790 | 0.320 |
Why?
|
| Brachial Plexus | 2 | 2009 | 20 | 0.310 |
Why?
|
| Retrospective Studies | 11 | 2023 | 16003 | 0.300 |
Why?
|
| Cognition | 1 | 2013 | 735 | 0.300 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2008 | 40 | 0.290 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 1260 | 0.290 |
Why?
|
| Anxiety | 1 | 2014 | 956 | 0.290 |
Why?
|
| Calcium Signaling | 2 | 2023 | 241 | 0.290 |
Why?
|
| Tissue Scaffolds | 1 | 2008 | 73 | 0.280 |
Why?
|
| Depression | 2 | 2022 | 1226 | 0.280 |
Why?
|
| Immunohistochemistry | 3 | 2017 | 1682 | 0.270 |
Why?
|
| Decompression, Surgical | 2 | 2004 | 92 | 0.270 |
Why?
|
| Analgesics, Opioid | 2 | 2023 | 401 | 0.270 |
Why?
|
| Time Factors | 8 | 2022 | 6204 | 0.270 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2021 | 142 | 0.270 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 2528 | 0.260 |
Why?
|
| Eye Movements | 2 | 2017 | 69 | 0.260 |
Why?
|
| Cerebral Cortex | 2 | 2021 | 434 | 0.250 |
Why?
|
| Aged, 80 and over | 5 | 2017 | 6373 | 0.250 |
Why?
|
| RNA, Messenger | 4 | 2017 | 2813 | 0.250 |
Why?
|
| Mice, Transgenic | 5 | 2021 | 2390 | 0.250 |
Why?
|
| Ulnar Nerve Compression Syndromes | 1 | 2004 | 2 | 0.240 |
Why?
|
| Elbow | 1 | 2004 | 7 | 0.240 |
Why?
|
| Ulnar Nerve | 1 | 2004 | 13 | 0.240 |
Why?
|
| Germinoma | 1 | 2004 | 31 | 0.240 |
Why?
|
| Thoracic Outlet Syndrome | 1 | 2004 | 12 | 0.240 |
Why?
|
| Nervous System Neoplasms | 1 | 2004 | 11 | 0.230 |
Why?
|
| Carpal Tunnel Syndrome | 1 | 2004 | 19 | 0.230 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2004 | 68 | 0.230 |
Why?
|
| Brain Concussion | 3 | 2016 | 225 | 0.230 |
Why?
|
| Postoperative Complications | 4 | 2023 | 3011 | 0.220 |
Why?
|
| G-Quadruplexes | 1 | 2023 | 9 | 0.220 |
Why?
|
| Glasgow Coma Scale | 2 | 2014 | 199 | 0.220 |
Why?
|
| Morphine Derivatives | 1 | 2023 | 6 | 0.220 |
Why?
|
| Decompression | 1 | 2023 | 5 | 0.220 |
Why?
|
| Chondrocytes | 2 | 2017 | 49 | 0.220 |
Why?
|
| Infrared Rays | 1 | 2023 | 20 | 0.220 |
Why?
|
| Aptamers, Nucleotide | 1 | 2023 | 24 | 0.220 |
Why?
|
| Clonidine | 1 | 2023 | 35 | 0.220 |
Why?
|
| Pyrans | 2 | 2021 | 6 | 0.210 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2016 | 239 | 0.210 |
Why?
|
| Arousal | 1 | 2023 | 82 | 0.210 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2023 | 49 | 0.210 |
Why?
|
| Hedgehog Proteins | 2 | 2016 | 192 | 0.210 |
Why?
|
| Intracranial Pressure | 5 | 2017 | 176 | 0.210 |
Why?
|
| Animals, Newborn | 2 | 2016 | 991 | 0.210 |
Why?
|
| Prognosis | 4 | 2019 | 4507 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2023 | 3527 | 0.200 |
Why?
|
| Anesthetics, Local | 1 | 2023 | 80 | 0.200 |
Why?
|
| Epinephrine | 1 | 2023 | 174 | 0.200 |
Why?
|
| Intracranial Aneurysm | 2 | 2018 | 93 | 0.190 |
Why?
|
| Brain Edema | 3 | 2018 | 67 | 0.190 |
Why?
|
| Endarterectomy, Carotid | 1 | 2022 | 92 | 0.190 |
Why?
|
| Doxycycline | 1 | 2022 | 117 | 0.190 |
Why?
|
| Hyponatremia | 1 | 2022 | 70 | 0.190 |
Why?
|
| Transplantation, Homologous | 2 | 2014 | 659 | 0.190 |
Why?
|
| Treatment Outcome | 10 | 2022 | 12121 | 0.190 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2021 | 12 | 0.190 |
Why?
|
| Phosphoproteins | 2 | 2023 | 399 | 0.190 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 1672 | 0.180 |
Why?
|
| Carotid Stenosis | 1 | 2022 | 133 | 0.180 |
Why?
|
| Coccyx | 1 | 2020 | 3 | 0.180 |
Why?
|
| Surgical Wound Infection | 1 | 2023 | 260 | 0.180 |
Why?
|
| SMARCB1 Protein | 1 | 2020 | 32 | 0.170 |
Why?
|
| Pain, Postoperative | 1 | 2023 | 255 | 0.170 |
Why?
|
| Sleep | 1 | 2023 | 348 | 0.170 |
Why?
|
| DNA-Binding Proteins | 2 | 2021 | 2047 | 0.170 |
Why?
|
| Seizures | 2 | 2016 | 871 | 0.170 |
Why?
|
| Patient Readmission | 1 | 2023 | 366 | 0.170 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2019 | 30 | 0.170 |
Why?
|
| Cognitive Dysfunction | 1 | 2023 | 222 | 0.170 |
Why?
|
| Cell Survival | 3 | 2019 | 803 | 0.170 |
Why?
|
| Cancer Pain | 2 | 2017 | 24 | 0.160 |
Why?
|
| Child, Preschool | 5 | 2017 | 13874 | 0.160 |
Why?
|
| Collagen Type II | 2 | 2017 | 24 | 0.160 |
Why?
|
| Risk Factors | 5 | 2023 | 10017 | 0.160 |
Why?
|
| Eye Movement Measurements | 2 | 2017 | 3 | 0.160 |
Why?
|
| Ischemic Postconditioning | 1 | 2018 | 4 | 0.160 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2016 | 29 | 0.160 |
Why?
|
| Infant | 3 | 2020 | 12334 | 0.160 |
Why?
|
| Hydrogen Peroxide | 1 | 2019 | 113 | 0.150 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2016 | 137 | 0.150 |
Why?
|
| Ocimum sanctum | 1 | 2018 | 2 | 0.150 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 352 | 0.150 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2023 | 542 | 0.150 |
Why?
|
| Cell Count | 2 | 2016 | 247 | 0.150 |
Why?
|
| Chronic Pain | 1 | 2020 | 127 | 0.150 |
Why?
|
| Length of Stay | 2 | 2014 | 1285 | 0.150 |
Why?
|
| Blotting, Western | 2 | 2018 | 1101 | 0.150 |
Why?
|
| Genes, Neoplasm | 1 | 2018 | 80 | 0.150 |
Why?
|
| Biomarkers | 3 | 2016 | 2941 | 0.150 |
Why?
|
| Glucosides | 1 | 2018 | 46 | 0.150 |
Why?
|
| Neoplasms | 2 | 2023 | 2762 | 0.140 |
Why?
|
| Flavonoids | 1 | 2018 | 78 | 0.140 |
Why?
|
| Quality Improvement | 1 | 2023 | 623 | 0.140 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2017 | 19 | 0.140 |
Why?
|
| Thoracic Vertebrae | 1 | 2017 | 66 | 0.140 |
Why?
|
| Bumetanide | 1 | 2016 | 7 | 0.140 |
Why?
|
| Nogo Receptor 1 | 2 | 2014 | 9 | 0.140 |
Why?
|
| Trauma Centers | 1 | 2018 | 171 | 0.140 |
Why?
|
| User-Computer Interface | 2 | 2008 | 153 | 0.140 |
Why?
|
| Spinal Neoplasms | 1 | 2017 | 59 | 0.140 |
Why?
|
| Cell Membrane Permeability | 1 | 2016 | 73 | 0.140 |
Why?
|
| Depressive Disorder, Major | 1 | 2022 | 401 | 0.140 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2017 | 67 | 0.140 |
Why?
|
| Calpain | 1 | 2016 | 41 | 0.140 |
Why?
|
| Behavior, Animal | 2 | 2022 | 476 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 288 | 0.140 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2016 | 31 | 0.130 |
Why?
|
| Head Protective Devices | 1 | 2016 | 24 | 0.130 |
Why?
|
| Pancreatic Stellate Cells | 1 | 2016 | 7 | 0.130 |
Why?
|
| Cerebrovascular Circulation | 2 | 2017 | 424 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2019 | 467 | 0.130 |
Why?
|
| Visual Perception | 1 | 2017 | 125 | 0.130 |
Why?
|
| Ammonia | 1 | 2016 | 68 | 0.130 |
Why?
|
| Catheters, Indwelling | 1 | 2017 | 155 | 0.130 |
Why?
|
| Substance P | 1 | 2016 | 33 | 0.130 |
Why?
|
| Melatonin | 1 | 2016 | 25 | 0.130 |
Why?
|
| TRPV Cation Channels | 1 | 2016 | 34 | 0.130 |
Why?
|
| Facial Nerve | 1 | 2016 | 25 | 0.130 |
Why?
|
| Thrombocytopenia | 1 | 2018 | 228 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2023 | 826 | 0.130 |
Why?
|
| Evoked Potentials | 1 | 2016 | 133 | 0.130 |
Why?
|
| Radiosurgery | 1 | 2017 | 106 | 0.130 |
Why?
|
| Nerve Growth Factors | 1 | 2016 | 72 | 0.130 |
Why?
|
| Survival Rate | 2 | 2018 | 1993 | 0.130 |
Why?
|
| Tubulin | 1 | 2016 | 106 | 0.130 |
Why?
|
| Intracranial Hypertension | 1 | 2017 | 116 | 0.130 |
Why?
|
| Neuroma, Acoustic | 1 | 2016 | 29 | 0.130 |
Why?
|
| Protease Inhibitors | 1 | 2016 | 95 | 0.130 |
Why?
|
| Preoperative Care | 2 | 2016 | 350 | 0.130 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2016 | 167 | 0.130 |
Why?
|
| Microglia | 1 | 2016 | 95 | 0.130 |
Why?
|
| Ischemia | 1 | 2018 | 337 | 0.130 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2016 | 87 | 0.130 |
Why?
|
| Electrophysiology | 1 | 2016 | 268 | 0.130 |
Why?
|
| Blood Platelets | 1 | 2018 | 333 | 0.120 |
Why?
|
| Exosomes | 1 | 2015 | 41 | 0.120 |
Why?
|
| Frontotemporal Dementia | 1 | 2015 | 40 | 0.120 |
Why?
|
| Endothelial Cells | 1 | 2019 | 527 | 0.120 |
Why?
|
| Sex Factors | 2 | 2016 | 1257 | 0.120 |
Why?
|
| Abducens Nerve Diseases | 1 | 2014 | 7 | 0.120 |
Why?
|
| Pyrroles | 1 | 2016 | 178 | 0.120 |
Why?
|
| Oculomotor Nerve Diseases | 1 | 2014 | 17 | 0.120 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 1873 | 0.120 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 572 | 0.120 |
Why?
|
| Ocular Motility Disorders | 1 | 2015 | 38 | 0.120 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 1001 | 0.120 |
Why?
|
| S100 Calcium Binding Protein A6 | 1 | 2014 | 2 | 0.120 |
Why?
|
| Child | 6 | 2017 | 24219 | 0.120 |
Why?
|
| Glycoproteins | 1 | 2016 | 369 | 0.120 |
Why?
|
| Stroke | 1 | 2022 | 958 | 0.120 |
Why?
|
| Single-Blind Method | 1 | 2014 | 235 | 0.110 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 669 | 0.110 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2014 | 58 | 0.110 |
Why?
|
| Horses | 1 | 2014 | 89 | 0.110 |
Why?
|
| Critical Care Nursing | 1 | 2014 | 6 | 0.110 |
Why?
|
| S100 Calcium Binding Protein beta Subunit | 1 | 2014 | 16 | 0.110 |
Why?
|
| Photolysis | 1 | 2013 | 9 | 0.110 |
Why?
|
| Medulla Oblongata | 1 | 2013 | 22 | 0.110 |
Why?
|
| Neuroblastoma | 1 | 2019 | 509 | 0.110 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2013 | 20 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2016 | 1010 | 0.110 |
Why?
|
| Pyrazoles | 1 | 2016 | 303 | 0.110 |
Why?
|
| Trauma Severity Indices | 1 | 2014 | 87 | 0.110 |
Why?
|
| Physical Exertion | 1 | 2014 | 80 | 0.110 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 515 | 0.110 |
Why?
|
| Infant, Newborn | 2 | 2017 | 8101 | 0.110 |
Why?
|
| Brain Stem Neoplasms | 1 | 2013 | 39 | 0.110 |
Why?
|
| Athletes | 1 | 2014 | 61 | 0.110 |
Why?
|
| Injury Severity Score | 1 | 2014 | 219 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 1584 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 1336 | 0.110 |
Why?
|
| Explosions | 1 | 2012 | 8 | 0.110 |
Why?
|
| Rats, Wistar | 1 | 2014 | 359 | 0.110 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2013 | 169 | 0.110 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 5047 | 0.100 |
Why?
|
| Glutamic Acid | 1 | 2013 | 194 | 0.100 |
Why?
|
| Hematoma, Subdural, Chronic | 1 | 2012 | 9 | 0.100 |
Why?
|
| Hypothermia, Induced | 1 | 2013 | 161 | 0.100 |
Why?
|
| Immunogenetic Phenomena | 1 | 2012 | 1 | 0.100 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2012 | 122 | 0.100 |
Why?
|
| Sciatic Nerve | 1 | 2012 | 54 | 0.100 |
Why?
|
| Neuroimaging | 1 | 2015 | 332 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 2114 | 0.100 |
Why?
|
| Age Factors | 2 | 2016 | 2799 | 0.100 |
Why?
|
| Brachial Plexus Neuritis | 1 | 2011 | 5 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 576 | 0.090 |
Why?
|
| Mice, Knockout | 3 | 2014 | 3714 | 0.090 |
Why?
|
| Cell Line, Tumor | 4 | 2021 | 3267 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 1866 | 0.090 |
Why?
|
| Progesterone | 1 | 2013 | 624 | 0.090 |
Why?
|
| Anticonvulsants | 1 | 2013 | 370 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2019 | 3046 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 509 | 0.090 |
Why?
|
| Cerebral Ventricles | 1 | 2011 | 80 | 0.090 |
Why?
|
| Hypoxia | 1 | 2012 | 244 | 0.090 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2011 | 141 | 0.090 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 921 | 0.090 |
Why?
|
| Intracranial Hemorrhages | 1 | 2011 | 73 | 0.090 |
Why?
|
| Intensive Care Units | 1 | 2014 | 481 | 0.090 |
Why?
|
| Feasibility Studies | 2 | 2016 | 752 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 673 | 0.090 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 507 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2014 | 1167 | 0.080 |
Why?
|
| Brachial Plexus Neuropathies | 1 | 2009 | 10 | 0.080 |
Why?
|
| Pyridines | 1 | 2011 | 224 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 2837 | 0.080 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2009 | 64 | 0.080 |
Why?
|
| Guided Tissue Regeneration | 1 | 2008 | 3 | 0.080 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2011 | 317 | 0.080 |
Why?
|
| Cartilage, Articular | 1 | 2009 | 59 | 0.080 |
Why?
|
| Databases, Factual | 1 | 2013 | 1169 | 0.080 |
Why?
|
| Monitoring, Physiologic | 1 | 2011 | 354 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 2481 | 0.080 |
Why?
|
| Lung Diseases | 1 | 2012 | 385 | 0.080 |
Why?
|
| Hemangioma | 1 | 2009 | 94 | 0.080 |
Why?
|
| Myelin Sheath | 1 | 2009 | 132 | 0.080 |
Why?
|
| Incidence | 1 | 2016 | 3050 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 1308 | 0.080 |
Why?
|
| Wound Healing | 1 | 2012 | 452 | 0.080 |
Why?
|
| Factor VIIa | 1 | 2008 | 24 | 0.070 |
Why?
|
| beta Catenin | 1 | 2009 | 205 | 0.070 |
Why?
|
| Osteoarthritis | 1 | 2009 | 87 | 0.070 |
Why?
|
| Stress, Mechanical | 1 | 2008 | 171 | 0.070 |
Why?
|
| Hemostatics | 1 | 2008 | 57 | 0.070 |
Why?
|
| Texas | 1 | 2016 | 3546 | 0.070 |
Why?
|
| Dementia | 1 | 2012 | 448 | 0.070 |
Why?
|
| Positive-Pressure Respiration | 1 | 2007 | 83 | 0.070 |
Why?
|
| Smoking | 1 | 2012 | 1031 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 287 | 0.070 |
Why?
|
| Neuroprotective Agents | 1 | 2008 | 146 | 0.070 |
Why?
|
| Interleukin-1beta | 2 | 2016 | 159 | 0.060 |
Why?
|
| Electromyography | 2 | 2021 | 161 | 0.060 |
Why?
|
| Autophagy | 2 | 2021 | 391 | 0.060 |
Why?
|
| Microsurgery | 1 | 2005 | 70 | 0.060 |
Why?
|
| Neurofibroma | 1 | 2004 | 6 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2014 | 1158 | 0.060 |
Why?
|
| Respiration, Artificial | 1 | 2007 | 452 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 1385 | 0.060 |
Why?
|
| Mutation | 3 | 2023 | 5771 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2007 | 369 | 0.050 |
Why?
|
| Intracranial Hypotension | 1 | 2003 | 10 | 0.050 |
Why?
|
| Spinal Puncture | 1 | 2003 | 53 | 0.050 |
Why?
|
| Skull Base | 1 | 2003 | 54 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2023 | 165 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 1681 | 0.050 |
Why?
|
| Carotid Arteries | 1 | 2022 | 151 | 0.050 |
Why?
|
| Functional Laterality | 2 | 2013 | 181 | 0.040 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2020 | 22 | 0.040 |
Why?
|
| Apoptosis | 2 | 2018 | 1781 | 0.040 |
Why?
|
| Patient Selection | 1 | 2004 | 686 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2023 | 351 | 0.040 |
Why?
|
| Low Back Pain | 1 | 2020 | 34 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 2044 | 0.040 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 155 | 0.040 |
Why?
|
| Tight Junctions | 1 | 2019 | 37 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 94 | 0.040 |
Why?
|
| Malondialdehyde | 1 | 2018 | 35 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 2019 | 106 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2018 | 123 | 0.040 |
Why?
|
| Permeability | 1 | 2019 | 118 | 0.040 |
Why?
|
| Peroxidase | 1 | 2018 | 61 | 0.040 |
Why?
|
| Metabolomics | 1 | 2022 | 409 | 0.040 |
Why?
|
| Phytochemicals | 1 | 2018 | 8 | 0.040 |
Why?
|
| Thrombopoiesis | 1 | 2018 | 12 | 0.040 |
Why?
|
| Alanine Transaminase | 1 | 2018 | 151 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2018 | 140 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 531 | 0.040 |
Why?
|
| Reperfusion Injury | 1 | 2018 | 102 | 0.040 |
Why?
|
| Algorithms | 2 | 2014 | 1593 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2019 | 240 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 1062 | 0.040 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2017 | 60 | 0.030 |
Why?
|
| Narcotics | 1 | 2017 | 63 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 315 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 812 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2018 | 340 | 0.030 |
Why?
|
| Pedigree | 1 | 2020 | 1582 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 860 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2018 | 258 | 0.030 |
Why?
|
| Capsaicin | 1 | 2016 | 17 | 0.030 |
Why?
|
| Spine | 1 | 2017 | 143 | 0.030 |
Why?
|
| Nerve Growth Factor | 1 | 2016 | 24 | 0.030 |
Why?
|
| Binding Sites | 1 | 2019 | 1291 | 0.030 |
Why?
|
| Swine | 2 | 2011 | 1154 | 0.030 |
Why?
|
| Stents | 1 | 2022 | 868 | 0.030 |
Why?
|
| Nanotubes | 1 | 2015 | 13 | 0.030 |
Why?
|
| United States | 3 | 2018 | 10626 | 0.030 |
Why?
|
| Prions | 1 | 2015 | 13 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2016 | 233 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2016 | 277 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2016 | 118 | 0.030 |
Why?
|
| Motion Pictures | 1 | 2014 | 8 | 0.030 |
Why?
|
| Pancreas | 1 | 2016 | 210 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 350 | 0.030 |
Why?
|
| Automation | 1 | 2014 | 59 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2015 | 78 | 0.030 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2014 | 28 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 692 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 664 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 330 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2018 | 471 | 0.030 |
Why?
|
| Certification | 1 | 2014 | 67 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2014 | 312 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2014 | 112 | 0.030 |
Why?
|
| SNARE Proteins | 1 | 2013 | 22 | 0.030 |
Why?
|
| Anisotropy | 1 | 2013 | 122 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2014 | 217 | 0.030 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 83 | 0.030 |
Why?
|
| Sports | 1 | 2014 | 59 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2013 | 155 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2013 | 129 | 0.030 |
Why?
|
| Neural Inhibition | 1 | 2013 | 105 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2014 | 312 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2022 | 3334 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 818 | 0.030 |
Why?
|
| ROC Curve | 1 | 2013 | 556 | 0.020 |
Why?
|
| Atrophy | 1 | 2012 | 225 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 280 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 2584 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 696 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 4221 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2011 | 60 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2011 | 101 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2018 | 1907 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2011 | 114 | 0.020 |
Why?
|
| Oximetry | 1 | 2011 | 158 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 1311 | 0.020 |
Why?
|
| Students, Medical | 1 | 2014 | 361 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2011 | 197 | 0.020 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2009 | 51 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 3081 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2011 | 243 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2009 | 58 | 0.020 |
Why?
|
| Memory | 1 | 2012 | 360 | 0.020 |
Why?
|
| Learning | 1 | 2012 | 361 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 1565 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 272 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 1796 | 0.020 |
Why?
|
| Embolization, Therapeutic | 1 | 2009 | 226 | 0.020 |
Why?
|
| Homeostasis | 1 | 2011 | 682 | 0.020 |
Why?
|
| Respiration | 1 | 2007 | 123 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2011 | 862 | 0.020 |
Why?
|
| Biopsy | 1 | 2009 | 1239 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2012 | 3249 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 6028 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2016 | 4493 | 0.010 |
Why?
|
| Blood Patch, Epidural | 1 | 2003 | 5 | 0.010 |
Why?
|